Document is current
Any future updates will be listed below
-
Authors
Degtjarik, Oksana https://orcid.org/0000-0002-1492-9481
Golovenko, Dmitrij https://orcid.org/0000-0003-0120-1405
Diskin-Posner, Yael https://orcid.org/0000-0002-9008-8477
Abrahmsén, Lars
Rozenberg, Haim https://orcid.org/0000-0002-2023-5187
Shakked, Zippora https://orcid.org/0000-0003-1298-4716
-
Funding
Funding for this research was provided by:
Aprea Therapeutics AB. Kimmelman Center for Biomolecular Structure and Assembly (Weizmann Institute of Science).
- License Information
-
More Information
Article History
Received: 21 January 2021
Accepted: 5 November 2021
First Online: 3 December 2021
Competing interests
: L.A. is an Employee and equity holder of Aprea Therapeutics, developing eprenetapopt. All other authors declare no competing interests.
